Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate the effects of genetic polymorphisms on pharmacokinetic and pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


NCT number NCT01482117
Study type Interventional
Source Inje University
Contact
Status Completed
Phase N/A
Start date November 2011
Completion date February 2012

See also
  Status Clinical Trial Phase
Completed NCT02926326 - The Effect of Azithromycin on BCT197 Exposure in Healthy Male Volunteers Phase 1
Completed NCT04257955 - COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer
Recruiting NCT04249674 - Impact of CYP2D6 Genetic Polymorphisms on the Vulnerability to Drug-drug Interactions With Tramadol
Terminated NCT04842981 - Interleukin-6 Inhibitors and Drug-drug Interactions in Patients With Rheumatoid Arthritis Phase 1/Phase 2
Completed NCT01447472 - -Methylenedioxymethamphetamine (MDMA, Ecstasy) Induced Changes in Drug Metabolism: Gender and Genetic Polymorphisms Phase 1
Completed NCT03498170 - The Effect of Itraconazole on BCT197 Exposure in Healthy Male Participants Phase 1
Recruiting NCT06053411 - Contribution of UGT2B17 to the Pharmacokinetics of Diclofenac Early Phase 1
Completed NCT06411509 - Integration of Tai Chi and Repetitive Transcranial Magnetic Stimulation for Sleep Disturbance in Older Adults N/A
Active, not recruiting NCT05425303 - System Dynamics Model for Acute Non-contact Lower Extremity Injuries Prediction
Completed NCT02067936 - Walking the Isobole of Drug Interaction N/A
Completed NCT05365451 - Pharmacokinetic Drug-Drug Interaction Study to Identify Biomarkers of Kidney Transporters Early Phase 1